Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes

B Hofmann1, P Nishanian, T Nguyen

  • 1Center for Interdisciplinary Research in Immunology and Disease, Johnson Comprehensive Cancer Center, University of California, Los Angeles 90024-1747.

Insights

Human immunodeficiency virus (HIV) proteins impair T lymphocyte proliferation by activating the protein kinase A (PKA) pathway. This leads to increased cAMP, biochemical changes, and T cell anergy, hindering immune response.

Area of Science:

  • Immunology
  • Molecular Biology
  • Virology

Background:

  • Normal T lymphocyte proliferation is crucial for effective immune responses.
  • Human immunodeficiency virus (HIV) infection is known to impair T lymphocyte function.
  • The precise mechanisms underlying HIV-induced T cell dysfunction require further elucidation.

Purpose of the Study:

  • To investigate the molecular mechanisms by which HIV proteins impair T lymphocyte proliferation.
  • To identify key signaling pathways involved in HIV-induced T cell anergy.
  • To explore the role of cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) in this process.

Main Methods:

  • Assessed the induction of protein tyrosine kinases and PKA pathway in CD4+ and CD8+ T cells upon HIV protein exposure.
  • Measured intracellular cAMP levels in T lymphocytes.
  • Utilized agents like cholera toxoid and 8-bromo-cAMP to modulate cAMP/PKA activity.
  • Evaluated the activity of protein kinase C (PKC) upon stimulation.
  • Tested the effect of cAMP-reducing agents on HIV-induced T cell impairment.

Main Results:

  • HIV proteins actively impair T lymphocyte proliferation through induction of protein tyrosine kinases.
  • HIV-induced impairment is linked to the activation of the inhibitory PKA pathway, accompanied by increased intracellular cAMP.
  • Elevated cAMP/PKA activity leads to biochemical changes that inhibit phytohemagglutinin-stimulated T-lymphocyte proliferation.
  • External agents that increase cAMP/PKA activity mimicked HIV's inhibitory effect on proliferation.
  • HIV exposure decreased membrane-associated PKC activity, a proliferation promoter.
  • Agents reducing cAMP generation restored T-lymphocyte proliferation, neutralizing HIV's effect.

Conclusions:

  • HIV-induced augmentation of cAMP/PKA activity is a key mechanism contributing to T lymphocyte anergy.
  • This pathway disruption significantly impacts the proliferative capacity of T cells during HIV infection.
  • Targeting the cAMP/PKA pathway may offer therapeutic strategies to restore T cell function in HIV-infected individuals.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...